X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Glatt Selected for GMP Biorefinery Engineering Project by NSTDA in Thailand

Content Team by Content Team
11th September 2020
in News
Glatt Selected for GMP Biorefinery Engineering Project by NSTDA in Thailand

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

National Science and Technology Development Agency Thailand (NSTDA) is implementing the Government’s Thailand 4.0 initiative to promote strategic biotechnology growth at the country’s Eastern Economic Corridor of Innovation (EECi). One part of this new BIOPOLIS complex is the GMP Biorefinery Pilot Plant at EECi, for which German engineering company Glatt Ingenieurtechnik was selected to provide the engineering services. The contract between NSTDA and Glatt comprises the Conceptual and Basic Design phases for the GMP Biorefinery.

The main objective of the GMP Biorefinery Pilot Plant at EECi is to provide a “non-proprietary (generic) equipment” platform for private and public organizations, as well as local and international universities to scale-up and validate their laboratory prototypes and perform techno-economic feasibility studies before investing in specific production lines.

The Biorefinery platform will be designed in such a way that allows users to reconfigure the unit operation arrangement (“LEGO® box” concept) and adjust the operating parameters to extreme values to optimize the process conditions (flexible process window for optimization) and customize or scale-up the equipment. Glatt Ingenieurtechnik in Germany will lead the engineering project and design the biotech process plant.

Eastern Economic Corridor of Innovation (EECi) aims to advance and transform existing industries, both within the EEC and in other parts of the Thailand, through innovative research and development and advanced laboratory scale technology development to actual industrial application. Innovative Agriculture and Biorefinery are among the target industries of EECi. Thailand has developed a basic infrastructure to support the growth of the Biorefinery industry. Thailand’s Government has approved the investment policy infrastructure at EECi as a central facility to advance targeted Biorefinery technologies to higher Technology Readiness Level (TRL).

National Science and Technology Development Agency Thailand (NSTDA) is a government agency established to promote the development of science and technology in Thailand. NSTDA has multiple cooperations worldwide with research institutes, innovate industry, university and many companies. NSTDA was established in December 1991 as an autonomous Government agency under the National Science and Technology Development Act 1991. NSTDA is affiliated to the Ministry of Higher Education, Science, Research and Innovation, with the Minister serving as the chairman of NSTDA Governing Board. NSTDA is entrusted with an important task to accelerate science, technology and innovation development in Thailand to respond to the need of the industry and enhance the country’s competitiveness in the global economy, and as a result, making contribution to national economic and social development. NSTDA’s mission is to perform and support Research and Development, Design and Engineering, Technology Transfer, Science and Technology Human Resource Development and Infrastructure Development. This mission is implemented through working with partners from academic, government, private, and non-government sectors, both domestically and internationally.

Glatt Ingenieurtechnik GmbH plans and carries out international projects from the enlargement or modernization of existing production facilities to the construction of whole new factories. In doing so, the company combines professional engineering with sound technical know-how derived from patented process technologies it has developed itself, such as Glatt powder synthesis and fluidized and spouted bed methods for granulation and coating processes. The focus of the projects is on processes in the field of particle design and particle engineering for the development, optimization, functionalization and production of powder and bulk goods such as granulates and pellets for food, feed, chemicals and fine chemicals and processes for the manufacture of biotechnological and chemical active ingredients for sterile and non-sterile dosage forms of drugs.

Within the competence area of Process & Plant Engineering the company provides long year competences in biotechnological projects as well as in chemical synthesis engineering and has wide project experience in Asia, including Thailand, India, China, Vietnam, Bangladesh and further countries.

Previous Post

World's Largest Virtual Pharma Expo Agenda Unveiled:

Next Post

New Concept Allows Physical Partnering Event

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
New Concept Allows Physical Partnering Event

New Concept Allows Physical Partnering Event

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In